13 Memory CD4+ T cells expressing HLA-DR contribute to HIV persistence during prolonged ART

13 Memory CD4+ T cells expressing HLA-DR contribute to HIV persistence during prolonged ART

Bibliographic Details
Main Authors:	E. Lee, B. Hiener, P. Bacchetti, W. Shao, E. Boritz, D. Douek, R. Fromentin, T. Liegler, S.G. Deeks, F.M. Hecht, J. Milush, N. Chomont, S. Palmer
Format:	Article
Language:	English
Published:	Elsevier 2016-07-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020309584

Similar Items

Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy
by: Eunok Lee, et al.
Published: (2019-09-01)

Intact proviruses from naive and effector memory T-cells match persistent viremia
by: K. Fisher, et al.
Published: (2019-12-01)

The genetic traits of full-length HIV sequenced from memory T cell subsets
by: B.A. Horsburgh, et al.
Published: (2017-12-01)

Cellular proliferation maintains genetically intact and defective HIV-1 over time
by: B. Horsburgh, et al.
Published: (2019-07-01)

Cell proliferation contributes to the increase of genetically intact HIV over time
by: S. Palmer, et al.
Published: (2019-12-01)

Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants
by: Bonnie Hiener, et al.
Published: (2017-10-01)

HIV persistence in lymph nodes from virally suppressed individuals: residual production VS latency
by: M. Pardons, et al.
Published: (2017-12-01)

The impact of ART duration on the infection of T cells within anatomic sites
by: E. Lee, et al.
Published: (2017-12-01)

Single-cell transcriptome sequencing of latently-infected cells ex vivo using PCR-activated cell sorting (PACS)
by: E. Boritz, et al.
Published: (2019-12-01)

Association of HLA-DR3 and HLA-DR15 Polymorphisms with Risk of Systemic Lupus Erythematosus
by: Ke Xue, et al.
Published: (2018-01-01)

Tipificação das especificidades HLA-DR e HLA-DQ
by: Eduardo A. Donadi, et al.
Published: (2000-03-01)

DIFFERENTIAL IMPACT OF HLA-A, HLA-B AND HLA-DR COMPATIBILITY ON THE RENAL ALLOGRAFT SURVIVAL
by: V. Y. Abramov, et al.
Published: (2012-09-01)

HLA-G Dimers in the Prolongation of Kidney Allograft Survival
by: Maureen Ezeakile, et al.
Published: (2014-01-01)

Structure of the HLA-DR-DQ-genotype in children with coeliac disease
by: Yu. A. Dmitrieva, et al.
Published: (2020-07-01)

The curious case of HLA‐DR‐positive APL
by: Kanta Devi, et al.
Published: (2021-02-01)

Effect of Selenium on HLA-DR Expression of Thyrocytes
by: Csaba Bal&#225;zs, et al.
Published: (2012-01-01)

HLA-DR Association in Papillary Thyroid Carcinoma
by: Mahsa M. Amoli, et al.
Published: (2010-01-01)

Computational prediction of HLA-DR binding peptides
by: Brooks, Anthony J.
Published: (1999)

Expression of HLA-DR in pheripheral nerve of amyotrophic lateral sclerosis
by: A.S.B. Oliveira, et al.
Published: (1994-12-01)

CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.
by: Rémi Fromentin, et al.
Published: (2016-07-01)

Molecular analysis of thymopentin binding to HLA-DR molecules.
by: Zuojia Liu, et al.
Published: (2007-12-01)

Letter Regarding “Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens”
by: Mireille El Ters, et al.
Published: (2020-10-01)

Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease
by: Zhongfang Wang, et al.
Published: (2018-02-01)

Association of leprosy with HLA-DR2 in a Southern Brazilian population
by: Visentainer J.E.L., et al.
Published: (1997-01-01)

Sustained HIV release by single persisting CD4+ T cells during latency disruption
by: J.M. Hataye, et al.
Published: (2015-12-01)

HLA-DR and HLA-DQ alleles in patients from the south of Brazil: markers for leprosy susceptibility and resistance
by: Peixoto Paulo R, et al.
Published: (2009-08-01)

Comparison of allele frequency for HLA-DR and HLA-DQ between patients with ECC and caries-free children
by: Bagherian A, et al.
Published: (2008-03-01)

Immunogenetic study of diabetes mellitus in relation to HLA DQ and DR
by: Gyanendra Singh, et al.
Published: (2020-01-01)

HLA-DR3 antigen in the resistance to idiopathic dilated cardiomyopathy
by: B. Jin, et al.
Published: (2016-01-01)

HLA-DR and DQ Antigens in Iraqi Patients with Behget's Disease
by: Ikbal Kh. AL-Joofy, et al.
Published: (2005-07-01)

Peptide binding predictions for HLA DR, DP and DQ molecules
by: Lund Ole, et al.
Published: (2010-11-01)

Association of HLA-DR/DQ polymorphisms with schizophrenia in Tunisian patients
by: Aicha Sayeh, et al.
Published: (2014-11-01)

Persistent High Percentage of HLA-DR+CD38high CD8+ T Cells Associated With Immune Disorder and Disease Severity of COVID-19
by: Juan Du, et al.
Published: (2021-09-01)

HLA-B60 and HLA-DR4 alleles in Javanese children with steroid-sensitive primary nephrotic syndrome
by: M P Damanik
Published: (2016-10-01)

No evidence for prolonged visible persistence in patients with schizophrenia.
by: Cathleen Grimsen, et al.
Published: (2013-01-01)

Norovirus Persistence in Oysters to Prolonged Commercial Purification
by: Roberta Battistini, et al.
Published: (2021-07-01)

The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA
by: Vadim Jucaud
Published: (2017-01-01)

Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition
by: Christopher Szeto, et al.
Published: (2020-09-01)

Associations of HLA DR and DQ molecules with Lyme borreliosis in Latvian patients
by: Kovalchuka Lilija, et al.
Published: (2012-08-01)

Prevalence of Autoantibodies and HLA DR, DQ in Type 1 Diabetes Mellitus
by: Shailja Singh, et al.
Published: (2016-07-01)